Biotech

All Articles

Recursion's mind ailment test shows scant documentation of efficacy

.Recursion has discovered with a very early exam of its own tech-enabled technique to medication dis...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Contact it a situation of good chemical make up: Acepodia, a biotech based upon Nobel Prize-winning...

Praxis epilepsy drug decreases seizures in stage 2 litigation

.Practice Precision Medicines has scored an additional midphase gain in epilepsy this year, with its...

Three directors surrender as Dyne posts blended data for DMD prospect

.After running away a scientific grip numerous years back, Dyne Therapeutics has actually revealed n...

Arrowhead fires off phase 3 records in rare metabolic ailment in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand ahead of a prospective showdown along ...

Pfizer, Valneva show lyme condition shot helpful for second booster

.Pfizer and also Valneva may have about pair of additional years to wait before they make the initia...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's study a discussion along with Ayla Ellison, Tough Biotech Managing Editor and Michelle Benz...

New data show how Bayer's asundexian neglected to avoid strokes

.Bayer suspended the phase 3 trial for its own factor XIa inhibitor asundexian behind time in 2014 a...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own various sclerosis (MS) med tolebrutinib to the FDA, execs hav...

Galapagos' stock up as fund shows intent to mold its own advancement

.Galapagos is coming under added pressure coming from investors. Having actually developed a 9.9% co...